Nasdaq

Firefly Neuroscience, Inc. Advances Neuropharmacology and Psychiatry with Innovative BNA™ Platform Supported by New Clinical Studies

Firefly Neuroscience, Inc. has announced two significant studies supporting its BNA™ platform, which uses advanced EEG technology to enhance drug efficacy evaluations and cognitive assessments in ...
Nasdaq

Firefly Neuroscience Joins NVIDIA Connect to Advance FDA-Cleared BNA™ Platform and Human Brain Foundation Model Initiative

Firefly collaborates with NVIDIA to enhance its BNA™ platform and aims to create a foundation model of the human brain. Firefly Neuroscience, Inc. has announced its acceptance into the NVIDIA Connect ...